Perfusion Tech ApS
CVR 38238213 · Private limited company (ApS) · Active · Medium risk
Perfusion Tech ApS is a Private limited company (ApS), founded on , based in København Ø. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 1.4% over the next 12 months, which is 1.0 times the average for Danish companies. 9 annual reports have been published, of which 1 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK -9.6m and a net result of DKK -12.7m. CEO: Declan Cassells.
Bankruptcy risk for Perfusion Tech ApS
1.0 × the average (1.41%) · higher risk than 77% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 38238213
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (9 years)
- Address
- Viborggade 70D, 1.
2100 København Ø - Municipality
- København
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 118k
- Auditor
- EY Godkendt Revisionspartnerselskab
- Audit opted out
- No
Warning signs
| Annual reports filed late | 1 of 9 |
| Missing annual report | No |
| Negative equity | Yes |
| Equity ratio | -210.2% |
| Current ratio | 31% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 3 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 20 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Gross profit | DKK -6.1m | DKK -9.0m | DKK -5.4m |
| Net profit | DKK -12.7m | DKK -14.5m | DKK -9.5m |
| Equity | DKK -9.6m | DKK 2.1m | DKK 2.9m |
| Total assets | DKK 4.6m | DKK 5.6m | DKK 8.8m |
| Cash | DKK 1.5m | DKK 2.3m | – |
| Short-term debt | DKK 14.2m | DKK 2.0m | – |
| Avg. employees | 11 | 11 | – |
Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · EY Godkendt Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 160 | ||
| 1 Jan 2024 – 31 Dec 2024 | 175 | ||
| 1 Jan 2023 – 31 Dec 2023 | 85 | ||
| 1 Jan 2022 – 31 Dec 2022 | 158 | ||
| 1 Jan 2021 – 31 Dec 2021 | 147 | ||
| 1 Jan 2020 – 31 Dec 2020 | 146 | ||
| 1 Jan 2019 – 31 Dec 2019 | 231 | Late | |
| 1 Jan 2018 – 31 Dec 2018 | 149 | ||
| 28 Nov 2016 – 31 Dec 2017 | 143 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Declan Cassells | Current | |
| CEO | Pernille Charlotte Singer | ||
| Board | Declan Cassells | Current | |
| Board | Jeppe Øvli Øvlesen | ||
| Board | Steffen Boutrup Møller | ||
| Board | Thomas Engelbrecht Nordkild Jonassen | ||
| Board | Morten Asp Vonsild Lund | ||
| Board | Mads Aagaard Linde Madsen | ||
| Board | Lars Henning Stigel | ||
| Board | Henrik Christensen | ||
| Board | Sten Scheibye | ||
| Board | Henrik Christensen | ||
| Board | Morten Asp Vonsild Lund | ||
| Board | Mads Aagaard Linde Madsen | ||
| Owner (100%) | Renew Pharmaceuticals Limited | Current | |
| Owner (15%) | TJ BIOTECH HOLDING ApS | ||
| Owner (15%) | ASBA CONSULTING ApS | ||
| Owner (5%) | Uddannelses- og Forskningsstyrelsen | ||
| Owner (15%) | QUANTASS ApS | ||
| Owner (25%) | M.T. Lund Holdings ApS | ||
| Owner (25%) | MHAaM Holdings ApS | ||
| Owner (5%) | Uddannelses- og Forskningsstyrelsen | ||
| Owner (10%) | Uddannelses- og Forskningsstyrelsen | ||
| Owner (10%) | TJ BIOTECH HOLDING ApS | ||
| Owner (10%) | QUANTASS ApS | ||
| Owner (20%) | M.T. Lund Holdings ApS | ||
| Owner (20%) | MHAaM Holdings ApS | ||
| Owner (10%) | Quantass ApS | ||
| Owner (10%) | TJ Biotech Holding ApS | ||
| Owner (5%) | Uddannelses- og Forskningsstyrelsen | ||
| Owner (15%) | M.T. Lund Holdings ApS | ||
| Owner (15%) | MHAaM Holdings ApS | ||
| Owner (5%) | TJ Biotech Holding ApS | ||
| Owner (15%) | Renew Pharmaceuticals Limited | ||
| Owner (5%) | Quantass ApS | ||
| Owner (25%) | Renew Pharmaceuticals Limited | ||
| Owner (10%) | M.T. Lund Holdings ApS | ||
| Owner (10%) | MHAaM Holdings ApS | ||
| Auditor | EY Godkendt Revisionspartnerselskab | Current | |
| Auditor | PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB | ||
| Founder | M.T. Lund Holdings ApS | Current | |
| Founder | MHAaM Holdings ApS | Current |
The CEOs' other companies
Pernille Charlotte Singer – 2 other companies
- Cacto Health ApS Active
- Intracair ApS Active
Address history (5 moves)
| Viborggade 70D, 1., 2100 København Ø | |
| Læssøesgade 20, kl. tv, 2200 København N | |
| c/o Mads Holst Aagaard Madsen, Slangerupgade 6, 3. th, 2200 København N | |
| c/o Mads Holst Aagaard Madsen, Ryesgade 107, 3. 2, 2100 København Ø | |
| c/o CAPNOVA A/S, Universitetsparken 7, 4000 Roskilde | |
| c/o Mads Holst Aagaard Madsen, Ryesgade 107, 3., 2100 København Ø |
Former names
| Perfusion Tech ApS | – now |
| Perfusion Tech IVS | – |
Other companies at the same address
- Birgitte Herskind No9 ApS Bankrupt
- CNK ApS Bankrupt
- SHUFFLEBOOK ApS Bankrupt
- Selskabet af 27. juni 2018 ApS Bankrupt
- WIL FILM ApS Bankrupt
- AKA Digital Imaging ApS Active
- BOLIGSIDEN A/S Active
- CAMEO FILM A/S Active
- Eurotroll Denmark ApS Active
- Hitch A/S Active
- Input interior Denmark A/S Active
- Jelly ApS Opløst
- Karmaman Viborggade ApS Opløst
- Little House Danmark ApS Active
- Little House Pakkerivej ApS Fusioneret
- Little House Restaurant ApS Active
- Little House Strandlodsvej ApS Fusioneret
- MINIMO ApS Opløst
- UPSIDEDOWNGAMES ApS Opløst
- WIL FILM ANIMATION ApS Opløst
Similar companies in København
- AffiCon ApS Valby
- EXTITUTION ApS København Ø
- Coco Sense ApS København NV
- Everllence Denmark A/S København SV
- BioSpectre ApS København V
- Nordic Cell Therapy Group ApS København N
- FiberSure ApS København Ø
- Tasira ApS København N
- Xenogen ApS København S
- Magnalev Core ApS København SV
- Pin Joint ApS København S
- Maglya ApS København Ø
Questions and answers about Perfusion Tech ApS
Has Perfusion Tech ApS gone bankrupt?
No, Perfusion Tech ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Perfusion Tech ApS?
Our model estimates a bankruptcy risk of 1.4% over the next 12 months (medium risk), which is 1.0 times the average for Danish companies.
Who is the CEO of Perfusion Tech ApS?
Declan Cassells is the CEO of Perfusion Tech ApS.
Who is the auditor of Perfusion Tech ApS?
Perfusion Tech ApS most recently used EY Godkendt Revisionspartnerselskab.
When was Perfusion Tech ApS founded?
Perfusion Tech ApS was founded on 28 November 2016.
What is the equity of Perfusion Tech ApS?
Equity was DKK -9.6m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.